Debra Silberg Ph.D

Debra Silberg Ph.D General Information

Biography

Dr. Debra Silberg serves as Board Member and Scientific Advisor at Ellodi Pharmaceuticals. She is an accomplished life sciences executive with deep experience across all stages of drug development. She serves as a Scientific Advisor to multiple pharmaceutical companies and has held clinical leadership roles at AstraZeneca, Shire, and most recently, Takeda, where Dr. Silberg served as the company's Global Vice President of Clinical Development and Clinical Science Head for Gastroenterology. She earned her BS degree at the University of Michigan, her PhD in Immunology from Wayne State University School of Medicine, and her MD from Albert Einstein College of Medicine. She completed her Internal Medicine Residency and Gastroenterology Fellowship at the University of Pennsylvania Health System. Dr. Silberg then became a faculty member in the Department of Medicine, Division of Gastroenterology at the University of Pennsylvania where she treated patients and was the principal investigator of a National Institutes of Health (NIH) funded molecular biology laboratory. She has been the recipient of seven NIH grants, published over 40 peer-reviewed articles, served on numerous national scientific committees, is a fellow of the American College of Gastroenterology, and a sought-after lecturer.